Virtus shares drop 20pc on profit downgrade

Original article by Yolanda Redrup
The Australian Financial Review – Page: 16 : 3-Jun-15

Australian-listed IVF group Virtus Health has slightly downgraded its net profit forecast for 2014-15. The group indicated in February 2015 that its market share was 45.6 per cent, but it advised on 2 June that bulk-billing providers in New South Wales have eroded its market share. Virtus shares closed 19.92 per cent lower at $A6.11.

CORPORATES
VIRTUS HEALTH LIMITED – ASX VRT, PRIMARY HEALTH CARE LIMITED – ASX PRY, QUADRANT PRIVATE EQUITY PTY LTD

Monash IVF confident on revenue

Original article by Jessica Gardner
The Australian Financial Review – Page: 28 : 26-Feb-15

Australian-listed Monash IVF has posted a 2014-15 interim net profit of $A11m, while enquiries from prospective patients rose by four per cent. CEO James Thiedeman forecasts that around 70 per cent of these enquiries will result in new patients for the group. Monash IVF shares closed $A0.05 higher at $A1.405 on 25 February 2015

CORPORATES
MONASH IVF GROUP LIMITED – ASX MVF, FLINDERS FERTILITY

Monash eyes small clinics and Asian leap

Original article by Jessica Gardner
The Australian Financial Review – Page: 19 : 29-Aug-14

Australian-listed Monash IVF has reported a 2013-14 net profit of $A2.6m, compared with a $A14.6m loss in 2012-13. The group’s revenue of $A114m was 18 per cent higher than previously, and earnings were bolstered by acquisitions and demand for IVF-related services. CEO James Thiedeman has indicated that the group plans to expand in Asia

CORPORATES
MONASH IVF GROUP LIMITED – ASX MVF, VIRTUS HEALTH LIMITED – ASX VRT, PRIMARY HEALTH CARE LIMITED – ASX PRY, MACQUARIE GROUP LIMITED – ASX MQG